Members |
targetComponentId |
Povidone-iodine 10% vaginal gel |
Iodine (as povidone iodine) 100 mg/g vaginal gel |
Povidone-iodine 20% topical sponge |
Povidone iodine only product in cutaneous dose form |
Povidone-iodine 200mg pessary |
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
Povidone-iodine 5% topical sponge |
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Powder for conventional release intravesical or parenteral or urethral solution |
Powder for conventional release intravesical solution and solution for injection (dose form) |
Powder for conventional release solution for endotracheal instillation |
Powder for solution for endotracheopulmonary instillation |
Powder for conventional release suspension for endotracheal instillation |
Powder for conventional release suspension for endotracheopulmonary instillation (dose form) |
Powder for suspension |
A solid dose form consisting of one or more particulate solids of varying degrees of fineness. |
Powered wheelchair |
Motorized wheelchair device (physical object) |
Poxvirus group |
Family Poxviridae (organism) |
Pramipexole dihydrochloride 125micrograms tablet |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug) |
Pramipexole dihydrochloride 1mg tablet |
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet |
Pramipexole dihydrochloride 250micrograms tablet |
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet |
Pramlintide 1mg/mL injection solution prefilled pen |
Pramlintide only product |
Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
Pre-eclampsia or eclampsia with pre-existing hypertension with postnatal complication |
Pre-eclampsia or eclampsia with pre-existing hypertension |
Pre-excitation atrioventricular conduction |
Accelerated atrioventricular conduction |
Pre-existing therapy altered by anesthetist preoperatively |
Pre-existing therapy altered by anesthetist preoperatively (situation) |
Pre-primary teacher NOS |
Pre-primary education teacher |
Pre-primary teacher NOS |
Pre-primary education teacher |
Pre-school diphtheria and tetanus double vaccination |
Preschool administration of diphtheria and tetanus vaccine |
Precautionary nursing procedure |
Nursing procedure |
Precerebral artery occlusion NOS |
Precerebral arterial occlusion |
Precerebral artery occlusion NOS |
Precerebral arterial occlusion |
Precipitate labor with antenatal problem |
Precipitate labor |
Prediabetes |
Characterized by blood glucose levels that are higher than normal but not yet high enough to be classed as diabetes. Indicates a relatively high risk for the future development of diabetes. |
Prednisolone 0.001% eye drops |
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
Prednisolone 0.003% eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 0.01% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
Prednisolone 0.01% eye drops |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
Prednisolone 0.01% preservative-free eye drops |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
Prednisolone 0.03% conventional release eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 0.03% eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 0.03% preservative-free eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 0.1% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
Prednisolone 0.1% eye drops |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
Prednisolone 0.1% preservative-free eye drops |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
Prednisolone 0.3% conventional release eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 0.3% eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 0.3% preservative-free eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
Prednisolone 20mg/100mL long tube retention enema |
Prednisolone only product in rectal dose form |
Prednisolone 20mg/100mL standard tube retention enema |
Prednisolone only product in rectal dose form |
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment |
Prednisolone and sulfacetamide only product in ocular dose form |
Prednisolone acetate 25mg/mL |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Prednisolone acetate 25mg/mL suspension |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Prednisolone drops allergy |
Allergy to prednisolone |
Prednisolone hexanoate 1.3mg / Cinchocaine 1mg suppository |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
Prednisolone sodium phosphate 0.5% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
Prednisolone sodium phosphate 0.5% single-use eye drops |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
Prednisolone sodium phosphate 1% solution |
Product containing precisely prednisolone sodium phosphate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Prednisolone sodium phosphate 1/8% solution |
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Prefabricated stainless steel crown, permanent tooth |
Restoration of permanent tooth with preformed stainless steel crown (procedure) |
Prefabricated stainless steel crown, primary tooth |
Restoration of deciduous tooth with preformed stainless steel crown (procedure) |
Preference for temperature of drink |
Preference for temperature of drink (observable entity) |
Preference for temperature of food |
Preference for temperature of food (observable entity) |
Preglaucoma |
At least 1 of these in 1 eye: optic nerve or nerve fibre layer suggestive of glaucoma; abnormal visual field consistent with glaucoma; an elevated IOP > 22 mm Hg. |
Pregnancy and drug dependence |
Pregnancy and substance dependence (disorder) |
Pregnancy benefit NOS |
Pregnancy benefits |
Pregnancy benefit NOS |
Pregnancy benefits |
Pregnancy complications NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
Pregnancy complications NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
Pregnancy prolonged - 41 weeks |
Gestation period extended beyond 42 weeks or 294 days from the first day of the last menstrual period. |
Pregnancy prolonged - 42 weeks |
Gestation period extended beyond 42 weeks or 294 days from the first day of the last menstrual period. |
Pregnancy with abortive outcome NOS |
Pregnancy with abortive outcome |
Pregnancy with abortive outcome NOS |
Pregnancy with abortive outcome |
Pregnancy with medical condition NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
Pregnancy with medical condition NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
Pregnancy with other medical condition |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
Pregnancy with other medical condition |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
Pregnancy, childbirth and puerperal disorders |
Disorder of pregnancy |
Pregnant woman |
Patient currently pregnant |
Premature abnormal placenta |
Premature aging of placenta |
Premature ejaculation |
Premature ejaculation |
Premature rupture of membranes with antenatal problem |
Premature rupture of membranes |
Prematurity of fetus |
Prematurity of infant (disorder) |
Premenstrual tension |
Premenstrual tension syndrome |
Prenatal vitamin |
Vitamin |
Preoperative nursing procedure |
Preoperative care |
Preoperative procedures |
Preoperative procedure |
Preputial skin flap |
Skin flap (substance) |
Preretinal fibrosis |
Epiretinal membrane |
Prescription telephone order |
Prescription ordered by telephone |
Presence of complement |
Complement assay |
Presence of complement component 3 |
Complement assay |
Presence of complement component 4 |
Complement assay |
Presence of drugs of abuse |
Drug, confirmation assay |
Presence of heavy metal |
Heavy metal screen |
Presence of interpreter |
Finding related to presence of interpreter (finding) |
Presence of interpreter |
Finding related to presence of interpreter (finding) |
Presence of interpreter |
Finding related to presence of interpreter (finding) |
Presence of pesticide |
Pesticides screen |
Pressure controlled synchronized intermittent mandatory ventilation |
Synchronized intermittent mandatory ventilation - pressure-control pressure-support inflation (regime/therapy) |
Pressure controlled ventilation |
Positive pressure ventilation |
Pressure on artery |
Pressure - action |
Pressure on limb artery |
Pressure - action |
Pressure ulcer |
Pressure injury |
Pressure ulcer |
Pressure injury (morphologic abnormality) |